United Therapeutics (UTHR) Gross Margin (2009 - 2026)
United Therapeutics (UTHR) reported Gross Margin of 82.93% for Q1 2026, down 543.0% on a YoY basis from 18.72% in Q1 2025, and down 4.58% sequentially from 86.91% in Q4 2025.
United Therapeutics (UTHR) Gross Margin (2009 - 2026) Analysis & Trends
United Therapeutics (UTHR) has 18 years of Gross Margin data on file, last reported at 82.93% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin fell 543.0% year-over-year to 82.93%; the trailing twelve-month figure through Mar 2026 stood at 86.58% (down 242.0% YoY), and the FY2025 full-year result was 87.92%, down 131.0% from the prior year.
- Gross Margin slipped to 82.93% in Q1 2026, from 86.91% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 94.39% in Q1 2022 to a low of 82.93% in Q1 2026.
- A 5-year average of 89.19% and a median of 89.03% in 2025 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin soared 197 bps in 2022 and sank 543 bps in 2026, its largest moves.
- Tracing UTHR's Gross Margin over 5 years: stood at 88.04% in 2022, then gained by 0 bps to 88.45% in 2023, then grew by 1 bps to 89.69% in 2024, then fell by 3 bps to 86.91% in 2025, then fell by 5 bps to 82.93% in 2026.
- Business Quant data shows UTHR's Gross Margin at 82.93% in Q1 2026, 86.91% in Q4 2025, and 87.38% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 55.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.93% |
| Dec 31, 2025 | 86.91% |
| Sep 30, 2025 | 87.38% |
| Jun 30, 2025 | 89.03% |
| Mar 31, 2025 | 88.36% |
| Dec 31, 2024 | 89.69% |
| Sep 30, 2024 | 88.90% |
| Jun 30, 2024 | 89.12% |
| Mar 31, 2024 | 89.24% |
| Dec 31, 2023 | 88.45% |
| Sep 30, 2023 | 88.50% |
| Jun 30, 2023 | 89.25% |
| Mar 31, 2023 | 89.68% |
| Dec 31, 2022 | 88.04% |
| Sep 30, 2022 | 92.79% |
| Jun 30, 2022 | 93.64% |
| Mar 31, 2022 | 94.39% |
| Dec 31, 2021 | 91.67% |
| Sep 30, 2021 | 93.77% |
| Jun 30, 2021 | 91.67% |